Saturday 17 October 2026 Export AKBA’s income statement to Excel — free account

Akebia Therapeutics, Inc.

AKBA Healthcare Drug Manufacturers Specialty & Generic

Akebia Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $236.2 million, up 47.5% from fiscal 2024. In the quarter to June 2026, revenue fell 21.4%, EPS fell 3,433.3%, free cash flow fell 89.0% and total debt rose 5.31%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.67 0.03 −4.29%

Follow AKBA

Alert me

Market cap: $192.7M
P/E: 0.0×
Fwd P/E: −6.3×
Dividend yield: —
F-score: 7/9
Altman Z: −4.42
Beneish M: −3.16
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	1.40	1.60	1.75	3.21
P/FCF ratio Full definition →	7.63	6.18	6.10	22.35
P/Operating CF Full definition →	87.19	(17.50)	13.30	25.72
P/B ratio Full definition →	12.29	13.56	12.70	17.38
Price to Tangible BV Full definition →	0.00	0.00	0.00	0.00
EV/Sales Full definition →	0.92	1.11	1.25	2.76
EV/EBITDA Full definition →	0.00	39.17	11.91	22.17
EV/Operating CF Full definition →	4.85	4.26	4.34	19.19
EV/FCF Full definition →	5.00	4.29	4.35	19.22
Quick Ratio Full definition →	1.30	1.30	1.42	1.74
Current Ratio Full definition →	1.43	1.40	1.55	1.94
Net Debt/EBITDA Full definition →	18.46	26.04	16.59	(24.92)
Debt/Assets Full definition →	14.17%	13.49%	12.81%	13.08%
Debt/Equity Full definition →	1.98	1.79	1.48	1.15
Asset Turnover Full definition →	0.63	0.69	0.79	0.79
Operating CF/Net income Full definition →	(0.40)	2.34	(2.54)	52.05
Capex/Depreciation Full definition →	(1.84)	(0.19)	(0.22)	(0.24)
Interest Coverage Full definition →	(2.06)	(1.00)	(1.77)	0.94
Research and Development Expense of Revenue Full definition →	28.62%	27.65%	46.25%	25.43%
Selling, General and Administrative Expense of Revenue Full definition →	57.34%	56.84%	45.28%	49.51%
Intangible Assets out of Total Assets Full definition →	0.17	0.16	0.16	0.16
Share Based Compensation of Revenue Full definition →	6.57%	6.85%	5.55%	5.48%
Graham Net Nets Full definition →	(0.31)	(0.25)	(0.22)	(0.09)
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(9.47%)	(5.55%)	(1.06%)	(2.46%)
Free Cash Flow Yield Full definition →	13.10%	16.17%	16.39%	4.47%
Revenue per Share Full definition →	0.18	0.20	0.22	0.22
Operating CF per Share Full definition →	0.01	(0.08)	0.12	0.11
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	0.01	(0.08)	0.12	0.11
Cash per Share Full definition →	0.58	0.61	0.72	0.63
Shareholders Equity per Share Full definition →	0.09	0.10	0.13	0.16
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	0.09	0.10	0.13	0.16
Free Cash Flow Full definition →	2.45	(21.27)	31.06	28.03
Working Capital Full definition →	68.69	69.60	90.02	124.96
Capital Expenditures Full definition →	(1.08)	(0.06)	(0.07)	(0.08)
Net Current Asset Value Full definition →	(95.09)	(91.66)	(91.00)	(64.22)
EV/EBIT Full definition →	0.00	48.67	12.55	35.03
Capex to Sales Full definition →	0.02	0.00	0.00	0.00
Price to Operating Income Full definition →	0.00	70.18	17.62	40.73
Other line items
Average Receivables Full definition →	63.16	62.04	40.70	49.20
Average Payables Full definition →	10.49	10.52	18.18	11.79
Average Inventory Full definition →	14.86	16.36	15.93	19.57
Average Assets Full definition →	347.63	336.35	298.62	285.65
Average Common Equity Full definition →	27.12	25.98	(8.29)	(4.41)

Show all line items

Columns are period end dates

Stockrow Weekly